Longenesis to raise €1 million from angel investors.

Longenesis, a Riga, Latvia-based SAAS developer of solutions in the area of biomedical research, announced raising funding of €1 million ($1.2M).

The money was raised mostly from angel investors including Rustam Gilfanov and Ilya Suharenko, one of the Managing Partners of LongeVC.

Longenesis, co founded in 2017 by Insilico Medicine and CEO Alex Zhavoronkov, has created an end-to-end environment for biomedical institutions, patient organizations and research partners and sponsors - to communicate directly, enabling both safe data curation and compliant, consent-enabled biomedical data utilization for research. The company has 3 core products: Longenesis Curator, Longenesis Themis, Longenesis Engage.